T cells as the hoped-for savior for SARS-CoV-2 vaccination during CD20-depleting antibody therapy?: Commentary for: “Discordant humoral and T cell immune responses to SARS-CoV-2 vaccination in people with multiple sclerosis on anti-CD20 therapy.”

Detalles Bibliográficos
Autores principales: Bsteh, Gabriel, Sellner, Johann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579751/
https://www.ncbi.nlm.nih.gov/pubmed/34773893
http://dx.doi.org/10.1016/j.ebiom.2021.103692
_version_ 1784596488580497408
author Bsteh, Gabriel
Sellner, Johann
author_facet Bsteh, Gabriel
Sellner, Johann
author_sort Bsteh, Gabriel
collection PubMed
description
format Online
Article
Text
id pubmed-8579751
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-85797512021-11-12 T cells as the hoped-for savior for SARS-CoV-2 vaccination during CD20-depleting antibody therapy?: Commentary for: “Discordant humoral and T cell immune responses to SARS-CoV-2 vaccination in people with multiple sclerosis on anti-CD20 therapy.” Bsteh, Gabriel Sellner, Johann EBioMedicine Commentary Elsevier 2021-11-10 /pmc/articles/PMC8579751/ /pubmed/34773893 http://dx.doi.org/10.1016/j.ebiom.2021.103692 Text en © 2021 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Commentary
Bsteh, Gabriel
Sellner, Johann
T cells as the hoped-for savior for SARS-CoV-2 vaccination during CD20-depleting antibody therapy?: Commentary for: “Discordant humoral and T cell immune responses to SARS-CoV-2 vaccination in people with multiple sclerosis on anti-CD20 therapy.”
title T cells as the hoped-for savior for SARS-CoV-2 vaccination during CD20-depleting antibody therapy?: Commentary for: “Discordant humoral and T cell immune responses to SARS-CoV-2 vaccination in people with multiple sclerosis on anti-CD20 therapy.”
title_full T cells as the hoped-for savior for SARS-CoV-2 vaccination during CD20-depleting antibody therapy?: Commentary for: “Discordant humoral and T cell immune responses to SARS-CoV-2 vaccination in people with multiple sclerosis on anti-CD20 therapy.”
title_fullStr T cells as the hoped-for savior for SARS-CoV-2 vaccination during CD20-depleting antibody therapy?: Commentary for: “Discordant humoral and T cell immune responses to SARS-CoV-2 vaccination in people with multiple sclerosis on anti-CD20 therapy.”
title_full_unstemmed T cells as the hoped-for savior for SARS-CoV-2 vaccination during CD20-depleting antibody therapy?: Commentary for: “Discordant humoral and T cell immune responses to SARS-CoV-2 vaccination in people with multiple sclerosis on anti-CD20 therapy.”
title_short T cells as the hoped-for savior for SARS-CoV-2 vaccination during CD20-depleting antibody therapy?: Commentary for: “Discordant humoral and T cell immune responses to SARS-CoV-2 vaccination in people with multiple sclerosis on anti-CD20 therapy.”
title_sort t cells as the hoped-for savior for sars-cov-2 vaccination during cd20-depleting antibody therapy?: commentary for: “discordant humoral and t cell immune responses to sars-cov-2 vaccination in people with multiple sclerosis on anti-cd20 therapy.”
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579751/
https://www.ncbi.nlm.nih.gov/pubmed/34773893
http://dx.doi.org/10.1016/j.ebiom.2021.103692
work_keys_str_mv AT bstehgabriel tcellsasthehopedforsaviorforsarscov2vaccinationduringcd20depletingantibodytherapycommentaryfordiscordanthumoralandtcellimmuneresponsestosarscov2vaccinationinpeoplewithmultiplesclerosisonanticd20therapy
AT sellnerjohann tcellsasthehopedforsaviorforsarscov2vaccinationduringcd20depletingantibodytherapycommentaryfordiscordanthumoralandtcellimmuneresponsestosarscov2vaccinationinpeoplewithmultiplesclerosisonanticd20therapy

Ejemplares similares